title: Revisiting the Serotonin Hypothesis: Implications for Major Depressive Disorders.
abstract: Major depressive disorder (MDD) is a heritable neuropsychiatric disease associated with severe changes at cellular and molecular levels. Its diagnosis mainly relies on the characterization of a wide range of symptoms including changes in mood and behavior. Despite the availability of antidepressant drugs, 10 to 30 % of patients fail to respond after a single or multiple treatments, and the recurrence of depression among responsive patients is very high. Evidence from the past decades suggests that the brain neurotransmitter serotonin (5-HT) is incriminated in MDD, and that a dysfunction of 5-HT receptors may play a role in the genesis of this disease. The 5-HT membrane transporter protein (SERT), which helps regulate the serotonergic transmission, is also implicated in MDD and is one of the main targets of antidepressant therapy. Although a number of behavioral tests and animal models have been developed to study depression, little is known about the neurobiological bases of MDD. Understanding the role of the serotonergic pathway will significantly help improve our knowledge of the pathophysiology of depression and may open up avenues for the development of new antidepressant drugs. The overarching goal of this review is to present recent findings from studies examining the serotonergic pathway in MDD, with a focus on SERT and the serotonin 1A (5-HT1A), serotonin 1B (5-HT1B), and serotonin 2A (5-HT2A) receptors. This paper also describes some of the main molecules involved in the internalization of 5-HT receptors and illustrates the changes in 5-HT neurotransmission in knockout mice and animal model of depression.
authors.affiliation: Department of Neuroscience, Faculty of Medicine, University of Montreal, Montreal, QC, H3C3J7, Canada. marc.fakhoury@umontreal.ca.
authors.forename: Marc
authors.initials: M
authors.lastname: Fakhoury
mesh_terms: D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D004195:Disease Models, Animal; D004705:Endocytosis / Q000187:drug effects; D006801:Humans; D008954:Models, Biological; D012701:Serotonin / Q000378:metabolism*
chemical_list: D000928:Antidepressive Agents; D012701:Serotonin
keywords: G-protein coupling; Gene knockout; Major depressive disorder; Serotonin; Serotonin receptor; Transporter
references.citation: Brain Res Brain Res Protoc. 2005 Dec;16(1-3):70-8
references.pmid: 16338640
references.citation: Mol Psychiatry. 2004 Oct;9(10):908-15
references.pmid: 15241435
references.citation: J Neurochem. 2003 Nov;87(4):861-7
references.pmid: 14622117
references.citation: Age (Dordr). 2010 Dec;32(4):483-95
references.pmid: 20508993
references.citation: Biochem Biophys Res Commun. 1992 Apr 30;184(2):752-9
references.pmid: 1315531
references.citation: Neuropsychopharmacology. 2006 Feb;31(2):265-77
references.pmid: 15999145
references.citation: J Neurosci Res. 2000 Jul 1;61(1):82-7
references.pmid: 10861803
references.citation: Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2542-6
references.pmid: 7681602
references.citation: Science. 2003 Jul 18;301(5631):386-9
references.pmid: 12869766
references.citation: J Neurochem. 2000 Dec;75(6):2415-26
references.pmid: 11080193
references.citation: Behav Brain Res. 2008 Dec 16;195(1):198-213
references.pmid: 18571247
references.citation: CNS Spectr. 2008 Nov;13(11):971-6
references.pmid: 19037176
references.citation: J Pharmacol Exp Ther. 1995 Dec;275(3):1638-46
references.pmid: 8531139
references.citation: Neuropsychopharmacology. 2001 Feb;24(2):141-51
references.pmid: 11120396
references.citation: Psychopharmacol Bull. 2001 Autumn;35(4):170-85
references.pmid: 12397864
references.citation: Neuropharmacology. 2001 Jun;40(7):899-910
references.pmid: 11378160
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2003 Feb;27(1):85-102
references.pmid: 12551730
references.citation: Brain Res. 2007 Sep 12;1169:87-97
references.pmid: 17692295
references.citation: Neuropsychopharmacology. 2002 Nov;27(5):852-61
references.pmid: 12431859
references.citation: Neuroscience. 1998 Apr;83(4):1185-201
references.pmid: 9502257
references.citation: Neuroscience. 2009 Feb 18;158(4):1406-15
references.pmid: 19111907
references.citation: J Neurochem. 2012 Dec;123(6):1054-68
references.pmid: 23061525
references.citation: FASEB J. 2008 Jun;22(6):1702-14
references.pmid: 18216289
references.citation: Neuropharmacology. 2005 Feb;48(2):204-14
references.pmid: 15695159
references.citation: Psychiatr Clin North Am. 2012 Mar;35(1):51-71
references.pmid: 22370490
references.citation: Neuropharmacology. 2000;39(1):110-22
references.pmid: 10665824
references.citation: Gen Hosp Psychiatry. 2015 Mar-Apr;37(2):172-7
references.pmid: 25772946
references.citation: Nat Struct Mol Biol. 2009 Jun;16(6):652-7
references.pmid: 19430461
references.citation: Psychopharmacology (Berl). 2012 Nov;224(2):313-25
references.pmid: 22707231
references.citation: Mol Pharmacol. 2008 Jan;73(1):178-90
references.pmid: 17947509
references.citation: EMBO J. 1991 Dec;10 (13):4017-23
references.pmid: 1836757
references.citation: Nucl Med Biol. 2000 Apr;27(3):249-54
references.pmid: 10832081
references.citation: Brain Res Mol Brain Res. 2002 May 30;101(1-2):39-51
references.pmid: 12007830
references.citation: Science. 1991 Oct 25;254(5031):579-80
references.pmid: 1948036
references.citation: Eur J Pharmacol. 2005 Jul 25;518(1):18-21
references.pmid: 15979608
references.citation: Pharm Biol. 2015 Mar;53(3):368-77
references.pmid: 25471378
references.citation: CNS Drugs. 2002;16(11):789-94
references.pmid: 12383038
references.citation: Philos Trans R Soc Lond B Biol Sci. 2013 Feb 25;368(1615):20120535
references.pmid: 23440469
references.citation: Eur J Pharmacol. 2000 Oct 27;407(1-2):39-46
references.pmid: 11050288
references.citation: Neuron. 1996 Nov;17(5):823-35
references.pmid: 8938116
references.citation: J Psychopharmacol. 1998;12(2):115-21
references.pmid: 9694022
references.citation: Mol Pharmacol. 2000 Dec;58(6):1271-8
references.pmid: 11093763
references.citation: Behav Pharmacol. 2004 Dec;15(8):523-34
references.pmid: 15577451
references.citation: Br J Pharmacol. 1999 Aug;127(8):1751-64
references.pmid: 10482904
references.citation: J Biol Chem. 2000 Jun 2;275(22):17201-10
references.pmid: 10748214
references.citation: Psychopharmacology (Berl). 2011 Feb;213(2-3):265-87
references.pmid: 21107537
references.citation: J Neurochem. 1994 Jun;62(6):2362-7
references.pmid: 8189241
references.citation: Am J Psychiatry. 2003 Jan;160(1):90-9
references.pmid: 12505806
references.citation: J Neurosci. 2004 Jun 9;24(23):5420-6
references.pmid: 15190115
references.citation: J Neurosci. 2005 Dec 7;25(49):11231-8
references.pmid: 16339018
references.citation: Rev Neurosci. 2012;23(4):429-43
references.pmid: 23089640
references.citation: Psychopharmacology (Berl). 2009 Aug;205(2):293-303
references.pmid: 19404615
references.citation: Biochem Soc Trans. 2001 Nov;29(Pt 6):722-8
references.pmid: 11709063
references.citation: Neurosci Lett. 2008 May 9;436(2):111-5
references.pmid: 18387740
references.citation: Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3712-7
references.pmid: 10097102
references.citation: Am J Psychiatry. 2004 Nov;161(11):2066-72
references.pmid: 15514408
references.citation: Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3020-4
references.pmid: 1557407
references.citation: Eur J Neurosci. 2000 Jul;12(7):2299-310
references.pmid: 10947809
references.citation: J Comp Neurol. 2000 Feb 7;417(2):181-94
references.pmid: 10660896
references.citation: Science. 1996 Jan 19;271(5247):363-6
references.pmid: 8553074
references.citation: Neuropharmacology. 1999 Sep;38(9):1421-30
references.pmid: 10471096
references.citation: Curr Top Behav Neurosci. 2011;7:121-47
references.pmid: 21225412
references.citation: J Neurochem. 2006 Nov;99(3):1019-31
references.pmid: 16981893
references.citation: Science. 2005 Apr 22;308(5721):512-7
references.pmid: 15845844
references.citation: Neurosci Biobehav Rev. 2005;29(4-5):627-47
references.pmid: 15925697
references.citation: J Soc Biol. 2004;198(1):30-6
references.pmid: 15146953
references.citation: Neuropsychopharmacology. 2002 Sep;27(3):380-90
references.pmid: 12225695
references.citation: CNS Neurosci Ther. 2010 Jun;16(3):e1-17
references.pmid: 20406250
references.citation: Philos Trans R Soc Lond B Biol Sci. 2013 Feb 25;368(1615):20120004
references.pmid: 23440462
references.citation: J Clin Psychiatry. 2014 Sep;75(9):e906-15
references.pmid: 25295433
references.citation: J Neurosci. 2001 Nov 1;21(21):8378-86
references.pmid: 11606626
references.citation: Curr Drug Targets. 2009 Nov;10(11):1118-38
references.pmid: 19702551
references.citation: Behav Brain Res. 2008 Nov 3;193(1):140-3
references.pmid: 18565601
references.citation: Neuropsychopharmacology. 2005 Jan;30(1):52-7
references.pmid: 15367926
references.citation: Pharmacol Ther. 2011 Mar;129(3):352-68
references.pmid: 21147164
references.citation: Neuropsychopharmacology. 2009 Jan;34(2):410-23
references.pmid: 18536707
references.citation: Neuron. 2009 May 28;62(4):479-93
references.pmid: 19477151
references.citation: J Neurosci. 2011 Apr 20;31(16):6008-18
references.pmid: 21508226
references.citation: J Neurochem. 2003 Apr;85(2):469-75
references.pmid: 12675923
references.citation: J Psychiatry Neurosci. 2004 Jul;29(4):252-65
references.pmid: 15309042
references.citation: Mol Psychiatry. 2013 Oct;18(10):1096-105
references.pmid: 23032875
references.citation: J Neurochem. 1993 Jun;60(6):2319-22
references.pmid: 7684072
references.citation: J Neurochem. 2003 Mar;84(6):1256-65
references.pmid: 12614326
references.citation: Neuropsychopharmacology. 2009 Jul;34(8):1958-67
references.pmid: 19322172
references.citation: J Pharmacol Exp Ther. 2001 Mar;296(3):987-95
references.pmid: 11181933
references.citation: J Am Acad Child Adolesc Psychiatry. 2002 Oct;41(10):1205-15
references.pmid: 12364842
references.citation: Trends Neurosci. 2000 Oct;23(10):459-65
references.pmid: 11006462
references.citation: Prog Neurobiol. 2009 May;88(1):17-31
references.pmid: 19428959
references.citation: J Psychiatry Neurosci. 2007 Mar;32(2):86-102
references.pmid: 17353938
references.citation: Annu Rev Physiol. 2007;69:511-34
references.pmid: 17305472
references.citation: J Psychiatry Neurosci. 2007 Jan;32(1):23-9
references.pmid: 17245471
references.citation: Eur J Pharmacol. 2003 Feb 28;463(1-3):177-84
references.pmid: 12600709
references.citation: J Psychiatry Neurosci. 2015 May;40(3):174-86
references.pmid: 25350320
references.citation: Drug Alcohol Depend. 2013 Dec 1;133(2):338-43
references.pmid: 23906994
references.citation: J Affect Disord. 2005 Nov;88(3):307-12
references.pmid: 16182374